Main Session
Sep
29
EDU 46 - Perioperative Immunotherapy in Head and Neck Cancer: Trial Data, Real-World Practice and Radiation Oncology Implications
Perioperative Immunotherapy in Locally Advanced Surgically Resectable Head and Neck Cancer: Review of KEYNOTE 689 Data
Presenter(s)
Robert Haddad, MD - Dana Farber Cancer Institute l, Boston, MA